Asia-Pacific Active Pharmaceutical Ingredients Market Outlook 2027

The Active Pharmaceutical Ingredients are the physical, chemical and therapeutically properties are governed by their molecular and their intermolecular interactions that affect the stability and solubility also influences the bioavailability, efficacy and dosage. The active Pharmaceutical ingredients are heavily dominated by china because of the price and technology advantages. In 2015 the government set up expert’s panel that recommend the establishments of active pharmaceuticals ingredients production parks and government incentives for R & D. Asia pacific. Asia pacific including six countries which is china, India Japan, Australia and South Korea. Based on synthesis The Asia pacific market is segmented into two parts which is biotech active pharmaceutical ingredients and synthetic active pharmaceutical ingredients. According to manufacturing type is segmented into captive and merchant Active Pharmaceutical ingredients. Rising adoption of biologics in disease management, increasing regulatory approvals, patent expiration of major drugs, growing trend of outsourcing and increase in geriatric population, using advance technologies for manufacturing of active pharmaceutical ingredients are the major driving factor. The API market has been categorized into branded or innovative prescription drugs, the generic prescription drugs, and OTC drugs. The branded or innovative prescription drugs accounted for a prominent share of the Asia pacific active pharmaceutical ingredients API market in 2022. Medicine use has continued to rise with people in the 5.8 billion prescriptions in 2018, increase of 2.7% over the previous year. An Favourable government initiatives, changing lifestyles leading to the development of diseases, rise in investment in R&D, and technological developments in drug manufacturing processes boost the market in the region. Synthetic APIs include ibuprofen, diclofenac, aspirin, and paracetamol. Biotech APIs are produced through living cells or microorganisms. They can be used for the treatment of various diseases such as cancer, diabetes, hypertension and others.

According to the report titled Asia-Pacific Active Pharmaceutical Ingredients Market Outlook, 2027, the Asia-Pacific active pharmaceutical ingredients market size was valued at USD 52.89 Billion in 2020 and is expected to expand at a CAGR of more than 8% from 2022 to 2027.

COVID-19 IMPACT.

In COVID-19 crisis food security, public health, and employment and labour issues, health and safety, converge. Adhering to workplace safety, health practices and ensuring access to decent work and the protection of labour rights, students in all industries will be crucial in addressing the human dimension of the crisis. Immediate and purposeful action to save lives and should include extending social protection towards universal health coverage and income support for those affected. An Include workers in the informal economy and in poorly protected and low-paid jobs, including, youth, older workers, and migrants and Particular attention must be paid to the situation of women who are over represented in low-paid jobs and care roles. Different forms of support are including cash transfers, child allowances and healthy school meals, shelter and food relief initiatives, support for employment retention and recovery, free ration distribution or financial relief in businesses including, micro, small and medium-sized enterprises. The designing and implementing such measures it is essential that governments work closely with employers and workers. All Countries dealing with existing humanitarian crises or emergencies are exposed to the effects of COVID-19. Responding to the pandemic, while ensuring that humanitarian and recovery assistance reaches those most in need, is critical.

Major Companies present in the market:

Aurobindo Pharma Limited, Cipla Limited, Dr. Reddy’s Laboratories Limited, Lupin Limited, Sun Pharmaceutical Industries Limited, Pfizer Inc., Novartis International AG, Biocon Limited, Sanofi S.A., Teva Pharmaceutical Industries Limited, AbbVie Inc., GlaxoSmithKline plc., Merck & Co., Inc., Viatris Inc., Bristol-Myers Squibb Company

Considered in this report

• Geography: Asia Pacific
• Historic Year: 2016
• Base year: 2021
• Estimated year: 2022
• Forecast year: 2027

Aspects covered in this report

• Asia Pacific Active Pharmaceutical Ingredients Market with its value and forecast along with its segments
• Region & country wise Active Pharmaceutical Ingredients market analysis
• Application wise Active Pharmaceutical Ingredients distribution
• Various drivers and challenges
• On-going trends and developments
• Top profiled companies
• Strategic recommendation

Countries covered in the report

• China
• India
• Japan
• Australia
• South Korea

Based on synthesis of Active Pharmaceutical Ingredients in the report:

• Synthetic APIs
• Biotech APIs

Based on drug type of Active Pharmaceutical Ingredients in the report:

• Branded APIs
• Generic APIs

Based on type of manufacture of Active Pharmaceutical Ingredients in the report:

• Captive APIs
• Merchant APIs

By Therapeutic Application Type in the report:

• Communicable Diseases
• Oncology
• Diabetes
• Cardiovascular Disease
• Pain management
• Respiratory Diseases
• Other Therapeutic Applications

The approach of the report:

This report consists of a combined approach of primary as well as secondary research. Initially, secondary research was used to get an understanding of the market and listing out the companies that are present in the market. The secondary research consists of third-party sources such as press releases, annual report of companies, analysing the government generated reports and databases. After gathering the data from secondary sources primary research was conducted by making telephonic interviews with the leading players about how the market is functioning and then conducted trade calls with dealers and distributors of the market. Post this we have started doing primary calls to consumers by equally segmenting consumers in regional aspects, tier aspects, age group, and gender. Once we have primary data with us we have started verifying the details obtained from secondary sources.

Intended audience

This report can be useful to industry consultants, manufacturers, suppliers, associations & organizations related to pharmaceutical industry, government bodies and other stakeholders to align their market-centric strategies. In addition to marketing & presentations, it will also increase competitive knowledge about the industry.

This report would help you answer the following questions:

1. What is the API data?
2. Which of the country consumes the most pharmaceuticals?
3. Which of the country is known as Pharmacy of world?
4. What are the trends in Pharmaceutical industry?
5. How many types of Active Pharmaceutical Ingredients are there?